Skip to content

Author

Xiang-Dong Li

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

MSTO1 promotes hepatocellular carcinoma progression and represents a potential target for immunotherapy.

The incidence of hepatocellular carcinoma (HCC) has increased over recent decades. While significant progress has been achieved in immunotherapy, the five-year survival rate is still unsatisfactory because of the low response rate and acquired resistance in a few patients, which reflects the complexity of the immune mi...

Xiang-Dong Li, Hao-Liang Zhu, Min-Hao Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.